Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01168596 · ClinicalTrials.gov registry record · Phase 4

Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease

A Phase 4 study of Parkinson's Disease, sponsored by University of Florida.

Completed
Registry status
Phase 4
Development phase
30
Enrollment target
3
Study locations

NCT01168596 is a Phase 4 study of Parkinson's Disease that has completed, run by University of Florida. The registered enrollment target is 30 participants, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01168596, a Phase 4 study of Parkinson's Disease, has completed, sponsored by University of Florida.

COMPLETED
Registry status
Phase 4
Development phase
30 participants
Enrollment target
3
Study locations

Study Summary

The purpose of the research study is to determine if rasagiline is an effective treatment for fatigue in patients with Parkinson's disease (PD).

Conditions Studied

Parkinson's Disease

Interventions

  • DRUG Placebo
  • DRUG Rasagiline

Study Locations (3)

Colorado

  • University of Colorado Anschutz outpatient Pavilion - Aurora

Florida

  • Shands and University of Florida Medical Plaza - Gainesville

Ohio

  • Cleveland Clinic Center for Neurological Restoration - Cleveland

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2009-12
Est. Completion 2012-05
Phase Phase 4

Sponsor

University of Florida

1,106 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01168596

The ClinicalTrials.gov registry entry for NCT01168596 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 642-participant average among 156 other Parkinson's Disease trials with a reported enrollment target (95% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01168596 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Florida, Ohio.

Frequently Asked Questions

What is clinical trial NCT01168596 about?

NCT01168596 is a clinical study titled "Rasagiline for the Symptomatic Treatment of Fatigue in Parkinson's Disease". The purpose of the research study is to determine if rasagiline is an effective treatment for fatigue in patients with Parkinson's disease (PD).

What is the current status of trial NCT01168596?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2009-12. Estimated completion is 2012-05.

What conditions does trial NCT01168596 study?

This clinical trial studies the following conditions: Parkinson's Disease.

What interventions are being tested in trial NCT01168596?

The interventions under investigation include: Placebo (DRUG), Rasagiline (DRUG).

Who is sponsoring clinical trial NCT01168596?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01168596 being conducted?

This trial has 3 study locations across Colorado, Florida, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Parkinson's Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Parkinson's Disease

All registered trials for this condition

Colorado

All trials with a study site in Colorado

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.